Artiva Biotherapeutics, Inc. (ARTV) Free cash flow 2023–2025
Artiva Biotherapeutics, Inc. (ARTV) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$79.3MFY2025 · since FY2023: -$50.7M → -$79.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$79.3M | -42.5% |
| FY2024 | -$55.7M | -9.8% |
| FY2023 | -$50.7M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice